After the isoxazoline gold rush: Where will industry turn for next big antiparasitic windfall?

摘要

The antiparasitic space has been an active battleground for the animal health industry for many decades. It is the largest single product market in animal health and will undoubtedly remain a key growth driver over the coming years. Animal Pharm editor Joseph Harvey canvassed opinion from a range of thought leaders on opportunities and challenges in this key blockbuster market. ...Moxidectin is a macrocyclic lactone antiparasitic compound. It is also the active ingredient in Zoetis' ProHeart 6, which has a six-month duration of action for preventing heartworm. ProHeart 12 is the same as ProHeart 6 but contains three times the concentration of moxidectin, enabling the longer duration of action.